BTI Biotechnology Institute is a biomedicine and biotechnology company whose activity focuses on the development of R&D+i projects, which it applies to its three basic fields of work: regenerative medicine, oral implantology and rehabilitation, and biomaterials.
BTI will be present at Yankee Dental Congress, the Annual Conference & Exposition for New England Dental Professionals. The conference features advanced programming presented by the leading experts from across the country.
Ideal solutions to solve cases with lack of bone substrate
Thanks to its precise diameters, the stress is distributed adequately in the first threads, making it possible to reduce the length without reducing surgical predictability. They have an apex modified to contain the highest nombre of complete threads.
BTI's research team has developed the therapeutic use of plasma rich in growth factors (PRGF®-EndoretTM).
PRGF®-EndoretTM Technology: It is the most advanced autologous Platelet-Rich Plasma system. It is based on the activation of the patient's own platelets for the stimulation and acceleration of tissue healing and regeneration.
It is a technology that allows the use of the organism's own resources with extraordinary results in many pathologies, effectively regenerating tissues without side effects and notably reducing the recovery period of fractures, muscular and tendinous injuries, and surgical interventions.
5 Day Seminar · Aula BTI USA 2014
The AULA BTI seminar includes a five day intensive course presenting a new Biological Approach to Implantology based on the most recent data and techniques developed by the Biotechnology Institute.
The educational objective of the course is to offer the attendees an innovative working method and predictable protocols, result of advanced scientific research and extensive clinical experience.